Unknown PHASE3 INTERVENTIONAL 2-arm NCT03237637

Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Interventions oral atenolol oral propranolol

Updated 9 times since 2017 Last updated: Aug 27, 2018 Started: Mar 24, 2017 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Infantile Hemangioma, this trial is ongoing. The trial is conducted by Post Graduate Institute of Medical Education and Research, Chandigarh and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Jul 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2021 — Apr 2024 [monthly]

Unknown Status PHASE3

▶ Show 4 earlier versions

Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Sep 2018 — Sep 2020 [monthly]

Recruiting PHASE3
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE3
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Post Graduate Institute of Medical Education and Research, Chandigarh

Data source: Post Graduate Institute of Medical Education and Research, Chandigarh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chandigarh, India